RESEARCH MONOGRAPH · KDC-MN-134

PEG-MGF (Mechano Growth Factor)

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

47/100

Real biology, fragile molecule, and the field has muddied what MGF actually is

Mechano growth factor is the IGF-1Ec splice variant produced in skeletal muscle in response to mechanical loading. Geoffrey Goldspink's group at UCL spent decades on this, showing that the alternatively-spliced E-domain at the C-terminus has distinct bioactivity from the mature IGF-1 peptide itself. The E peptide fragment (the last 24 residues, sometimes called MGF E-domain) appears to activate satellite cells and promote muscle regeneration through a receptor thats still not fully identified, separate from IGF-1R.

Heres the thing thats important. Native MGF is unstable. The E-domain peptide alone has a half-life measured in minutes, and the full IGF-1Ec protein gets cleaved rapidly. The pegylated version on the research market is a synthetic E-domain peptide with PEG conjugation to extend half-life, and the pegylation chemistry varies considerably between vendors. Some are doing N-terminal site-specific PEG, others are doing lysine PEGylation thats a heterogeneous mixture.

What we like: the underlying biology of mechanical-loading-triggered local IGF-1 splice variation is genuinely interesting and underappreciated outside skeletal muscle research circles. The Goldspink papers showing improved muscle regeneration in animal models are reproducible. There's a real research target here.

What we dont like: the research-market PEG-MGF products are frequently characterized weakly. The receptor pharmacology of the E-domain isn't sorted out, so you cant do clean receptor occupancy or selectivity studies. And the field has gotten polluted by bodybuilding-forum claims that overstate the human evidence dramatically.

Mechanism: poorly mapped past the level of "activates satellite cells and promotes proliferation." No defined receptor, no clean signaling cascade. Some evidence for ERK1/2 activation, some for SHP-2 involvement, but its not coherent yet.

Sourcing: this is where it gets rough. The PEG chemistry matters, the E-domain peptide is short and easy to make but easy to make wrong (oxidation, deamidation, incorrect folding). HPLC purity numbers from vendors are often quoted without showing the mass spec, which is the actual question. We'd want orthogonal characterization before trusting a vial.

Underrated biology, poorly served by the current research market. Treat with skepticism on the vendor side but pay attention to the underlying splice-variant story.

Evidence: 35
Mechanism: 40
Reliability: 45
Safety: 60
Sourcing: 40
Value: 50
Signal: 55
Staying power: 50

Plain-language summary Intrigue 65 / 100

PEG-MGF is a pegylated form of mechano-growth factor, a splice variant of IGF-1 produced in muscle in response to mechanical loading. The PEG group extends the half-life from minutes to days. Used in research for satellite cell activation and muscle repair. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Pegylated IGF-1 splice variant

A pegylated form of mechano growth factor (the IGF-1Ec splice variant) sold as a research peptide for muscle repair applications.

Abstract

PEG-MGF is a pegylated form of mechano growth factor (MGF), a splice variant of IGF-1 (IGF-1Ec) generated by exercise-induced muscle damage. MGF differs from systemic IGF-1 in containing a unique 24-residue C-terminal extension produced by alternative splicing of exon 5. The MGF C-terminal peptide alone (without the IGF-1 mature peptide) has been studied for muscle stem cell activation. Pegylation extends plasma half-life of the otherwise rapidly cleared peptide. The compound is sold as a research peptide; clinical evidence base in humans is sparse.

Mechanism of action

IGF-1Ec splice variant C-terminal peptide; muscle stem cell activation.

Reported research dose ranges

Reported research dose ranges in the literature.

References

Goldspink G. Mechano growth factor. Sports Med 2012.

Read the full monograph

Available as a research-use-only PDF download. Note: PDFs for newly added compounds may take a few hours to propagate after this article was published.

KDC-MN-134

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

PEG-MGF (Mechano Growth Factor)

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs